ATE190497T1 - Verwendung des rekombinanten koloniestimulierenden faktors-1 - Google Patents

Verwendung des rekombinanten koloniestimulierenden faktors-1

Info

Publication number
ATE190497T1
ATE190497T1 AT91917632T AT91917632T ATE190497T1 AT E190497 T1 ATE190497 T1 AT E190497T1 AT 91917632 T AT91917632 T AT 91917632T AT 91917632 T AT91917632 T AT 91917632T AT E190497 T1 ATE190497 T1 AT E190497T1
Authority
AT
Austria
Prior art keywords
stimulating factor
csf
recombinant colony
recombinant
colony
Prior art date
Application number
AT91917632T
Other languages
English (en)
Inventor
Peter Ralph
Kong T Chong
James Devlin
Robert Zimmerman
Sharon Lea Aukerman
David B Ring
Sylvia Hsieh Ma
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE190497T1 publication Critical patent/ATE190497T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91917632T 1990-08-23 1991-08-23 Verwendung des rekombinanten koloniestimulierenden faktors-1 ATE190497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57214990A 1990-08-23 1990-08-23
PCT/US1991/006052 WO1992003151A1 (en) 1990-08-23 1991-08-23 Uses of recombinant colony stimulating factor-1

Publications (1)

Publication Number Publication Date
ATE190497T1 true ATE190497T1 (de) 2000-04-15

Family

ID=24286555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917632T ATE190497T1 (de) 1990-08-23 1991-08-23 Verwendung des rekombinanten koloniestimulierenden faktors-1

Country Status (7)

Country Link
EP (2) EP0549702B1 (de)
JP (3) JP3501801B2 (de)
KR (1) KR100234870B1 (de)
AT (1) ATE190497T1 (de)
AU (1) AU646299B2 (de)
DE (1) DE69132051D1 (de)
WO (1) WO1992003151A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2181915T3 (es) * 1995-10-27 2003-03-01 Schering Corp Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
US6063372A (en) * 1995-10-27 2000-05-16 Inserm, Institut National De La Sante Et De La Recherche Medicale Uses of mammalian CTLA-8 and related reagents
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
DK1509256T3 (da) 2002-05-24 2009-11-23 Angiotech Int Ag Præparater og fremgangsmåde til coating af medicinske implantater
JP2007524671A (ja) * 2004-01-21 2007-08-30 カイロン コーポレイション Ｍ−ｃｓｆムテインおよびその使用
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
CN102648274B (zh) * 2009-12-09 2013-07-31 国立大学法人京都大学 包含双呋脒腙的促进多能干细胞分化成心肌细胞的组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856516T2 (de) * 1987-09-22 2002-10-10 Chiron Corp Verwendung von rekombinantem koloniestimulierendem Faktor-1 zur Herstellung eines Medikaments gegen Cytomegalovirusinfektionen

Also Published As

Publication number Publication date
EP0549702A1 (de) 1993-07-07
JP2002275089A (ja) 2002-09-25
JP3501801B2 (ja) 2004-03-02
KR930701186A (ko) 1993-06-11
DE69132051D1 (de) 2000-04-20
KR100234870B1 (ko) 1999-12-15
EP0549702B1 (de) 2000-03-15
AU646299B2 (en) 1994-02-17
JPH06500558A (ja) 1994-01-20
AU8647491A (en) 1992-03-17
JP2003292454A (ja) 2003-10-15
EP0955056A1 (de) 1999-11-10
WO1992003151A1 (en) 1992-03-05

Similar Documents

Publication Publication Date Title
FI864016A (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
ES2052580T3 (es) Nuevas formas de factor-1 estimulante de colonias.
RU2008146718A (ru) Способы лечения неврологических состояний с применением гематопоэтических факторов роста
ATE218882T1 (de) Gleichzeitige verarbeitung von interleukin-3 mutanten und kolonie stimulierungsfactor
KR900700475A (ko) 항균제
DK0790255T3 (da) Monoklonale antistoffer som er rettet mod den cytotoksiske lymfocytmodningsfaktor
DK0402068T3 (da) Polypeptider og polypeptidanaloger med inhiberende virkning mod human elastase
DE3856588D1 (de) Biologisch-aktive Bakterizide/permeabilitätserhöhende Proteinbruchstücke
FI813539L (fi) Maenniskans hybridleukosyt-interferoner
DE69206301T2 (de) Protein mit der Aktivität vom Typ von Cytokin, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
ATE190497T1 (de) Verwendung des rekombinanten koloniestimulierenden faktors-1
DK471386D0 (da) Farmaceutisk komposition til behandling af leukopeni
ATE403726T1 (de) Cytokin-proteinfamilie
DK12990D0 (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
CA2090121A1 (en) Uses of colony stimulating factor-1
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
ES2067948T3 (es) Compuestos biologicamente activos procedentes de algas verde-azuladas.
DK103891D0 (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
ES8703928A1 (es) Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante